Christina Fu

Christina (Runzhong) Fu, PhD, MS, is a Senior Principal Scientist in Immunogenicity Science at Pfizer, focusing on ADC bioanalytical assay development and immunogenicity risk assessment. Previously, Christina served as a Scientist at Seagen, leading a team on bioanalytical ligand-binding assay development and project management. Christina's research experience includes positions at institutions such as Keck School of Medicine of USC and Imperial College London, where they contributed to significant projects in pharmacology and drug discovery that resulted in multiple publications. Christina holds a PhD in Pharmacology from the University of Southern California and an MRes from Imperial College London.